895 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Mylan Institutional LLC recalled 800 vials of Haloperidol Lactate Injection on October 10, 2025, due to incorrect RFID tag labels. The product may pose a risk due to potential mislabeling affecting tracking and administration. Healthcare providers should stop using the product immediately and follow up with Safecor Health for guidance.
STAQ Pharma Inc. recalled Ketamine Hydrochloride 50mg/5 mL syringes on October 9, 2025. The recall affects products with incorrect or missing lot and expiration dates. The FDA classified this recall as Class III due to potential risks to patient safety.
STAQ Pharma Inc. recalled Hydromorphone HCL PF injections on October 9, 2025, due to incorrect or missing lot and expiration dates. The recall affects products distributed nationwide across the U.S. Healthcare providers and consumers must immediately cease using the affected medication.
STAQ Pharma Inc. recalled FentaNYL Citrate PF on October 9, 2025, due to incorrect or missing lot and expiration dates. The injection, distributed nationwide, poses a high hazard risk. Consumers and healthcare providers should stop using the product immediately.
American Health Packaging recalled 27,868 blister packs of Sucralfate Tablets on October 9, 2025. The company filed for Chapter 11 bankruptcy, impairing its ability to monitor product quality. Consumers should stop using the product immediately and seek guidance from healthcare providers.
USV Private recalled 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution on October 9, 2025. The solution exceeded impurity specifications, posing a health risk. Consumers should stop using the product immediately and contact their healthcare provider.
Taoscare recalled 3 boxes of motion sickness patches on October 9, 2025. The product was marketed without an approved NDA/ANDA. Consumers should stop using the patches immediately and seek guidance.
Glycar SA Pty. recalled 18 units of the SJM Pericardial Patch on October 9, 2025. The affected lot may not meet required tensile strength specifications. Healthcare providers and patients should stop using this device immediately.
Pivotal Health Solutions recalled 34 heated massage tables on October 9, 2025. The heat function may overheat, posing a risk of smoldering and melting. Affected units are distributed nationwide in the U.S., Canada, and Japan.
AstraZeneca recalled 916 pre-filled syringes of Fasenra on October 8, 2025. The recall follows a lack of assurance of sterility, posing serious health risks. Consumers and healthcare providers must stop using the product immediately.
Rising Pharma Holdings recalled 2,064 bottles of Carbidopa, Levodopa, Entacapone tablets on October 7, 2025. The recall followed reports that bottles contained incorrect dosages. The affected product poses a high risk due to potential overdose.
Zydus Lifesciences recalled 13,080 bottles of Tavaborole topical solution on October 6, 2025, due to discoloration. The recall affects products distributed nationwide in the USA. Consumers must stop using the product immediately and contact their healthcare providers for guidance.
Almpal recalled dissolved oxygen test kits on October 2, 2025. The kits contain unchild-resistant sulfuric acid, posing a poisoning risk to children. Consumers should stop using these kits immediately and secure them out of reach of children.
ICU Medical recalled 23,203 IV administration sets on October 2, 2025. The sets lack an internal shutoff valve, risking fluid over-delivery and air infusion. This recall affects devices distributed worldwide, including the U.S., Canada, Australia, and New Zealand.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Church & Dwight Co., Inc. recalled 21,912 bottles of ZICAM Medicated Fruit Drops on October 1, 2025. The recall stems from a labeling mix-up that failed to disclose elderberry as an ingredient. Consumers should stop using the product immediately.
Camber Pharmaceuticals, Inc. recalled Ketorolac Tromethamine Injection on October 1, 2025. The recall affects a specific lot due to the presence of glass particles. This recall pertains to the 60 mg/2 mL single-dose vials distributed nationwide.
B BRAUN MEDICAL recalled 1,298,454 hemodialysis bloodlines on September 30, 2025. The recall results from the risk of micro-air bubbles due to damaged connectors. Patients should stop using the product immediately and follow the manufacturer’s instructions.
SHENZHEN ATOMSTACK TECHNOLOGIES recalled material processing laser products on September 30, 2025, due to a missing remote interlock connector. This defect poses a high risk according to federal regulations. Consumers should stop using these devices immediately and follow manufacturer instructions for remedy.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.
Acella Pharmaceuticals recalled 4,680 bottles of Doxycycline Hyclate Tablets on September 29, 2025. The recall follows failed dissolution specifications, which can affect medication efficacy. This recall includes 500-count bottles distributed nationwide in the USA.
Medline Industries recalled 222,800 boxes of alcohol prep pads on September 29, 2025. The recall follows concerns the product may not meet potency standards. Consumers must stop using the pads and seek guidance from healthcare providers.
Philips Medical Systems Nederland B.V. recalled 29 Zenition 50 x-ray systems on September 29, 2025. The devices may suffer from corrosion of the Image Intensifier Television control board, leading to poor image quality. Users must stop using the device immediately and follow the recall instructions.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.